35 results
Page 2 of 2
8-K
EX-99.1
qua1 593kxbq
9 Nov 22
Absci Reports Third Quarter 2022 Financial Results
9:18am
8-K
EX-99.1
xjle8yn33048fhd
4 Oct 22
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
4:09pm
8-K
EX-99.1
0m58y
11 Aug 22
Absci Reports Second Quarter 2022 Financial Results and Business Update
8:33am
DEF 14A
aqd69m7ync52
26 Apr 22
Definitive proxy
4:39pm
10-K
pn70ea2efp
22 Mar 22
Annual report
5:20pm
8-K
EX-99.1
79jg0k9ggyc9ij0
22 Mar 22
Absci Reports Full Year 2021 Financial and Operating Results
4:07pm
424B4
vlixs cfta
23 Jul 21
Prospectus supplement with pricing info
4:49pm
S-1/A
gb78c ceu2
8 Jul 21
IPO registration (amended)
5:04pm
S-1
4fw 8nam6mgcg5j0
30 Jun 21
IPO registration
3:20pm
S-1
EX-10.11
12c95z
30 Jun 21
IPO registration
3:20pm
DRS/A
kjtay noifp
16 Jun 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.11
dvaa0mlqc eu
16 Jun 21
Draft registration statement (amended)
12:00am
DRS
n9j4x
6 May 21
Draft registration statement
12:00am